2021 Top Story
- Archives -Top story: University of Massachusetts announces $175 million transformational gift to its Medical School
The University of Massachusetts is announcing a history-making $175 million donation from The Morningside Foundation to UMass Medical School. (Originally published on Sept. 7, 2021)
Top story: UMass Medical School announces partnership in large-scale COVID-19 vaccination site in Worcester
UMass Medical School, in partnership with the Commonwealth of Massachusetts, the City of Worcester, Worcester State University and Saint Vincent Hospital, will play an integral role in a COVID-19 large-scale vaccination site that will open later this month on the campus of Worcester State. (Originally published on Feb. 17, 2021)
Top story: UMass Medical School researchers to start trial of Moderna COVID-19 vaccine in teens
UMass Medical School researchers are about to start enrolling adolescents ages 12 through 17 in a clinical trial to test the COVID-19 mRNA vaccine made by Moderna. (Originally published on Jan. 26, 2021)
Video: 2021 a banner year at UMass Chan Medical School
From a drive-in Match Day to new buildings on campus and a transformational gift, 2021 was a year to remember at UMass Chan Medical School. See highlights from the year in this video.
Communicating science: Brian Lewis discusses overcoming therapeutic resistance in pancreatic cancer
Brian Lewis, PhD, is studying therapeutic resistance in pancreatic cancer cells, hoping to change the grim statistics for patients diagnosed with pancreatic cancer.
UMass Chan student trustee focused on diversity, equity and inclusion
UMass Chan Medical School MD/PhD student Zach Dyer is serving as a student trustee on the University of Massachusetts Board of Trustees and is focused on diversity, equity and inclusion.
William Flavahan receives Distinguished Scientist Award for groundbreaking brain cancer research
William Flavahan, PhD, has received a four-year, $600,000 award from the Sontag Foundation to advance his studies of the genetic processes leading to brain tumors.
Caterina Strambio De Castillia and her team advance efforts to set microscopy data standards
UMass Chan Medical School researcher and Chan Zuckerberg Initiative Imaging Scientist Caterina Strambio De Castillia, PhD, is the senior author on two papers and a co-author on four more published in the December issue of Nature Methods.
Han lab developing light-activated immune cell therapy for cancers
Gang Han, PhD, said newly developed nano-optogenetic immunotherapy represents a new generation of personalized cancer treatment, in which precise control of the timing, location and dosage of T-cell activation could be tailored to an individual patient.
PhD student studies cancer tumor cells; follows path of high school science teacher
Emmet Karner, a PhD student in the Morningside Graduate School of Biomedical Sciences, was inspired by a passionate and influential teacher to go into the field.